Cost‐effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the <scp>LENS</scp> trial

Scotland, G., Tsehaye, M., Styles, C., Logue, J., Sammons, E., Zayed, M., Emberson, J., Wade, R., Wallendszus, K., Stevens, W., Cretney, R., Harding, S., Leese, G., Currie, G., Armitage, J. & Preiss, D., 3/07/2025, (E-pub ahead of print) In: Diabetic Medicine. e70098.

Research output: Contribution to Journal/Magazine › Journal article › peer-review